Loading…
Non-target Effects Of Dalaca pallens Blanchard Control Examined Through Principal Response Curves: A Guild Approach In Southern Chile
The non-target effects of biological control are a complex matter requiring a multi-approach analysis. A fungal biopesticide is under research to control the larval stages of the ghost moth Dalaca pallens Blanchard (Lepidoptera: Hepialidae) in southern Chile. A field experiment was conducted to comp...
Saved in:
Published in: | Chilean journal of agricultural research 2008-09, Vol.68 (3), p.228-237 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | eng ; por |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The non-target effects of biological control are a complex matter
requiring a multi-approach analysis. A fungal biopesticide is under
research to control the larval stages of the ghost moth Dalaca pallens
Blanchard (Lepidoptera: Hepialidae) in southern Chile. A field
experiment was conducted to compare the effects of the biological
control agent Beauveria bassiana (Balsamo) Vuillemin (1012 spores
ha-1) and the insecticide lambda-cyhalothrin (7.5 g active ingredient
ha-1) on non-target invertebrate species belonging to different guilds.
The soil invertebrates were collected by using pitfall trapping and
soil coring before and after spraying the biocontrol agent or the
insecticide. Caught individuals were assigned to predator, herbivore or
decomposer guilds and then a relatively new multivariate technique
called principal response curves (PRC) was adopted to track the
potential treatment effects over time in the abundance or activity of
the non-target guilds. The products targeting D. pallens caused
different effects on guilds: lambda-cyhalothrin decreased the
activity-density of the predator guild but not herbivore or decomposer
guilds, while the biological control agent caused no reduction in the
activity-density of the three examined guilds. The negative effects of
the insecticide were present from 1 to 60 days after treatment. |
---|---|
ISSN: | 0718-5820 0718-5839 0718-5839 |
DOI: | 10.4067/S0718-58392008000300002 |